Warning: The NCBI web site requires JavaScript to function. more...
Prevention of breast cancer by recapitulation of pregnancy hormone levels.
Tonetti DA.
Breast Cancer Res. 2004;6(1):E8.
Related citations
Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments.
Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S.
Breast Cancer Res. 2004;6(1):R31-7. Epub 2003 Nov 11.
Roles for estrogen and progesterone in breast cancer prevention.
Jerry DJ.
Breast Cancer Res. 2007;9(2):102.
Prevention of breast cancer: current state of the science and future opportunities.
Uray IP, Brown PH.
Expert Opin Investig Drugs. 2006 Dec;15(12):1583-600. Review.
Role of hormones in mammary cancer initiation and progression.
Russo IH, Russo J.
J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):49-61. Review.
Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Künzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR.
J Natl Cancer Inst. 2004 Feb 4;96(3):210-8.
Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA.
Labrie F.
Endocr Relat Cancer. 2006 Jun;13(2):335-55. Review.
Hormonal prevention of breast cancer: significance of promotional environment.
Lakshmanaswamy R, Guzman RC, Nandi S.
Adv Exp Med Biol. 2008;617:469-75.
Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.
Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S.
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2520-5.
Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer.
Tsubura A, Uehara N, Matsuoka Y, Yoshizawa K, Yuri T.
In Vivo. 2008 Mar-Apr;22(2):191-201. Review.
Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance.
Sengupta S, Jordan VC.
Adv Exp Med Biol. 2008;630:206-19. Review.
Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
Dunn BK, Ford LG.
Eur J Cancer Prev. 2007 Jun;16(3):232-42. Review.
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet. 2005 May 14-20;365(9472):1687-717.
Breast cancer risk with postmenopausal hormonal treatment.
Collins JA, Blake JM, Crosignani PG.
Hum Reprod Update. 2005 Nov-Dec;11(6):545-60. Epub 2005 Sep 8. Review. Erratum in: Hum Reprod Update. 2006 May-Jun;12(3):331.
Prevention of hormone-related cancers: breast cancer.
Dunn BK, Wickerham DL, Ford LG.
J Clin Oncol. 2005 Jan 10;23(2):357-67. Review.
Decreasing hormonal promotion is key to breast cancer prevention.
Rajkumar L, Canada A, Esparza D, Collins K, Moreno E, Duong H.
Endocrine. 2009 Apr;35(2):220-6. Epub 2009 Feb 12.
The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?
Jordan VC.
J Clin Oncol. 2008 Jun 20;26(18):3073-82. Epub 2008 Jun 2.
Selecting adjuvant endocrine therapy for breast cancer.
Eneman JD, Wood ME, Muss HB.
Oncology (Williston Park). 2004 Dec;18(14):1733-44, discussion 1744-5, 1748, 1751-4. Review.
AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.
Tower AM, Trinward A, Lee K, Joseph L, Jacobson HI, Bennett JA, Andersen TT.
Oncol Rep. 2009 Jul;22(1):49-56.
[Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].
Maeda T, Ke HZ, Simmons H, Thompson D.
Clin Calcium. 2004 Oct;14(10):85-93. Review. Japanese.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on